ProAssurance (PRA) Proxy Filing summary

Executive summary

• ProAssurance has agreed to be acquired by The Doctors Company, creating the second largest medical malpractice insurer and the largest physician-owned carrier in the U.S.

• The transaction aims to maintain high service standards, preserve the agent/broker distribution model, and uphold incentive programs through 2025.

• The deal is expected to close in the first half of 2026, pending shareholder, regulatory, and antitrust approvals.

• The combined entity will offer enhanced financial stability and expanded product options for healthcare providers.

• Forward-looking statements highlight potential risks, including regulatory approvals, business disruptions, and market uncertainties.

Voting matters and shareholder proposals

• Shareholders must approve the proposed acquisition as part of the closing conditions.

• Proxy statements and related materials will be filed with the SEC and distributed to stockholders.

Board of directors and corporate governance

• Information about directors and executive officers participating in the proxy solicitation is available in the 2025 annual meeting proxy statement.

• Any changes in security holdings by directors or officers will be disclosed in SEC filings.